Image 4_An updated framework for characterizing patients with pediatric feeding disorder.pdf por Valerie M. Volkert (22245610)

“...The current study assessed the acceptability and feasibility of the PFD CRF through data collection across three feeding programs involved in the initial development of the CRF. A total of 80 patients completed multidisciplinary team evaluations and contributed data to the current evaluation of clinical implementation. ...”

Image 3_An updated framework for characterizing patients with pediatric feeding disorder.pdf por Valerie M. Volkert (22245610)

“...The current study assessed the acceptability and feasibility of the PFD CRF through data collection across three feeding programs involved in the initial development of the CRF. A total of 80 patients completed multidisciplinary team evaluations and contributed data to the current evaluation of clinical implementation. ...”

Structural and Functional Dissection of GH161 β‑Glucan Phosphorylases: Molecular Specificities and Dynamics of Catalysis of Dimeric GH‑Q Enzymes por Nina J. Cooper (22606387)

“...Comparison between the unliganded form, the acceptor-bound form, and finally a catalytically active complex revealed conformational changes during catalysis that involve coordinated rearrangements within the active site, including loops held by the adjacent protomer. ...”

Structural and Functional Dissection of GH161 β‑Glucan Phosphorylases: Molecular Specificities and Dynamics of Catalysis of Dimeric GH‑Q Enzymes por Nina J. Cooper (22606387)

“...Comparison between the unliganded form, the acceptor-bound form, and finally a catalytically active complex revealed conformational changes during catalysis that involve coordinated rearrangements within the active site, including loops held by the adjacent protomer. ...”

Structural and Functional Dissection of GH161 β‑Glucan Phosphorylases: Molecular Specificities and Dynamics of Catalysis of Dimeric GH‑Q Enzymes por Nina J. Cooper (22606387)

“...Comparison between the unliganded form, the acceptor-bound form, and finally a catalytically active complex revealed conformational changes during catalysis that involve coordinated rearrangements within the active site, including loops held by the adjacent protomer. ...”

Structural and Functional Dissection of GH161 β‑Glucan Phosphorylases: Molecular Specificities and Dynamics of Catalysis of Dimeric GH‑Q Enzymes por Nina J. Cooper (22606387)

“...Comparison between the unliganded form, the acceptor-bound form, and finally a catalytically active complex revealed conformational changes during catalysis that involve coordinated rearrangements within the active site, including loops held by the adjacent protomer. ...”

Table 5_Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov.docx por Yinghong Zhou (6873053)

“...Aim<p>This study comprehensively analyzed the characteristics and development trends of pediatric interventional drug clinical trials registered between 2015 and 2024, with a focus on pharmaceutical characteristics such as dosage form and administration route.</p>Methods<p>The ClinicalTrials.gov database was searched to identify trials involving pediatric participants. ...”

Table 1_Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov.xlsx por Yinghong Zhou (6873053)

“...Aim<p>This study comprehensively analyzed the characteristics and development trends of pediatric interventional drug clinical trials registered between 2015 and 2024, with a focus on pharmaceutical characteristics such as dosage form and administration route.</p>Methods<p>The ClinicalTrials.gov database was searched to identify trials involving pediatric participants. ...”

Table 4_Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov.docx por Yinghong Zhou (6873053)

“...Aim<p>This study comprehensively analyzed the characteristics and development trends of pediatric interventional drug clinical trials registered between 2015 and 2024, with a focus on pharmaceutical characteristics such as dosage form and administration route.</p>Methods<p>The ClinicalTrials.gov database was searched to identify trials involving pediatric participants. ...”

Table 3_Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov.docx por Yinghong Zhou (6873053)

“...Aim<p>This study comprehensively analyzed the characteristics and development trends of pediatric interventional drug clinical trials registered between 2015 and 2024, with a focus on pharmaceutical characteristics such as dosage form and administration route.</p>Methods<p>The ClinicalTrials.gov database was searched to identify trials involving pediatric participants. ...”

Table 2_Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov.docx por Yinghong Zhou (6873053)

“...Aim<p>This study comprehensively analyzed the characteristics and development trends of pediatric interventional drug clinical trials registered between 2015 and 2024, with a focus on pharmaceutical characteristics such as dosage form and administration route.</p>Methods<p>The ClinicalTrials.gov database was searched to identify trials involving pediatric participants. ...”

Supplementary file 1_Prokineticin 2 neurons form diverse subpopulations in the suprachiasmatic nucleus and rely on VPAC2-signaling for diurnal rhythmicity.docx por Ida Stangerup (9576563)

The majority product of recombination by TelA (D398A) is a Holliday junction intermediate. por Shu Hui Huang (4557508)

Table illustrating inclusion criteria. por Colin Hamilton (3740026)

“...Nurses, Midwives and Allied Health Professionals form the largest group of healthcare professionals but are traditionally less involved in research than medically trained staff. ...”

Supplementary file 1_Mongolian medicine theory-based multidimensional evaluation of toxicity mitigation in Hezi-processed Caowu jointly mediated by powder dosage form and small dos... por Jing Wang (6206297)

“...Subsequently, in vitro toxicity mechanism studies were conducted on H9c2 cells using techniques such as MTT, fluorescent probes, ELISA, and Western blotting. Additionally, the involvement of the p38/JNK signaling pathway in their cardiotoxicity was verified by treating cells with p38/JNK pathway inhibitors....”

ResT (D328A) is inactive for telomere resolution but retains some ability to promote recombination. por Shu Hui Huang (4557508)

Analysis of gel-purified Holliday junctions produced by a hyperactive recombinase mutant. por Shu Hui Huang (4557508)

“...C) Shown are 0.8% agarose 1X TAE gels of the noted gel-purified forms analyzed by digestion with the HJ resolving enzyme T7 endonuclease I. lin denotes SspI-linearized substrate DNA; HJ_dimer denotes the presumptive HJ resulting from synapsis and strand exchange between monomers to produce a HJ for a dimer; HJ_mult denotes the presumptive product resulting from synapsis and strand exchange between full recombinants to produce a product with two HJs; HJ* denotes the presumptive products resulting from strand exchange between higher order recombinants to produce very large products connected by multiple HJs. ...”

Analysis of HJ’s produced with mutant <i>rTels</i> possessing sequence asymmetry between the scissile phosphates. por Shu Hui Huang (4557508)

Participant Characteristics (N = 150). por Panyasuda Yeetho (22552833)

“...</p><p>Methods</p><p>The sample involved 150 patients with COVID-19 after discharged from the university hospital. ...”

Descriptive report of social support (N = 150). por Panyasuda Yeetho (22552833)

“...</p><p>Methods</p><p>The sample involved 150 patients with COVID-19 after discharged from the university hospital. ...”